Skip to main content
Launch offer40% off your first paymentEnds 31 DecemberSee plans
Parabilis Medicines logo

Parabilis Medicines

Biotech & Pharmaceuticals
WebsiteLinkedIn

Parabilis is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines.

Open roles
3
Company size
51 - 200 employees
Headquarters
Cambridge, Massachusetts, United States

Follow Parabilis Medicines

Create an exact-company alert for on-site matches and optional daily email.

Open roles